Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)

NCT05524857 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Closed by Sponsor

Conditions

Myeloproliferative Neoplasm

Interventions

DRUG: Fedratinib Oral Capsule 300 mg
DRUG: Decitabine 20 mg/m2
DRUG: Fedratinib Oral Capsule 400 mg

Sponsor

Joseph Jurcic

Collaborators

[object Object]